← Leaderboards
Shan Lin
Seattle Children'S Hospital
$770,122
Attributed
$770,122
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$770,122 · 2
By mechanism
R00$497,962 · 1
K99$272,160 · 1
Top collaborators
No co-investigators on record.
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- Shaun William Jackson$9,327,534
- Janet E. Price$217,181
Others in their field
Other Emerging Leaders on “Crispr/Cas Technology”
- William H. Peranteau · Children'S Hosp Of Philadelphia$16,284,236
- Crystal Mackall · Children'S Hosp Of Philadelphia$13,090,386
- Jacqueline K White · Jackson Laboratory$11,881,166
- Jesse M Engreitz · Stanford University$8,776,071
- Peng Jiang · Rutgers, The State Univ Of N.J.$6,578,144
- Yin Shen · University Of California, San Francisco$6,515,212
Research focus
Crispr/Cas TechnologyAcute Myeloid Leukemia CellAcute Myelocytic LeukemiaCommunitiesApoptosis Regulation GeneApoptoticAwardAdvisory CommitteesBcl2 GeneAcute LeukemiaBiochemicalBiologicalCancer CellCancer SurvivalCareerCell DeathCell GrowthCell PhysiologyClinicClinical ApplicationClustered Regularly Interspaced Short Palindromic RepeatsApoptosisCollaborative EnvironmentCrispr Screen
Grant awards (4)
Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia$248,979
R00 · FY2025 · CA · contact PI
Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia$248,983
R00 · FY2024 · CA · contact PI
Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia$136,080
K99 · FY2022 · CA · contact PI
Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia$136,080
K99 · FY2021 · CA · contact PI